Creative Planning - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
Creative Planning ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$573,021
-17.3%
20,822
-28.9%
0.00%0.0%
Q2 2023$692,554
-6.8%
29,272
+0.0%
0.00%0.0%
Q1 2023$743,475
-17.3%
29,259
-26.4%
0.00%0.0%
Q4 2022$899,500
+48.4%
39,748
+0.9%
0.00%0.0%
Q3 2022$606,000
+13.7%
39,405
+99.5%
0.00%0.0%
Q2 2022$533,000
-24.0%
19,752
-49.8%
0.00%0.0%
Q1 2022$701,000
-8.0%
39,308
+99.5%
0.00%0.0%
Q4 2021$762,000
-41.5%
19,708
-18.3%
0.00%
-50.0%
Q3 2021$1,302,000
+61.5%
24,1080.0%0.00%
+100.0%
Q2 2021$806,000
+62.2%
24,108
-0.2%
0.00%0.0%
Q1 2021$497,000
-19.3%
24,147
-31.3%
0.00%0.0%
Q4 2020$616,000
+17.6%
35,147
-0.6%
0.00%0.0%
Q3 2020$524,000
+13.9%
35,3470.0%0.00%0.0%
Q2 2020$460,000
+2200.0%
35,347
+191.0%
0.00%
Q1 2020$20,000
-25.9%
12,1470.0%0.00%
Q4 2019$27,0000.0%12,147
-3.3%
0.00%
Q3 2019$27,000
-20.6%
12,566
+0.4%
0.00%
Q2 2019$34,000
-43.3%
12,513
+2.5%
0.00%
Q1 2019$60,00012,2130.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2021
NameSharesValueWeighting ↓
Kynam Capital Management, LP 2,600,000$88,218,00012.13%
Octagon Capital Advisors LP 759,898$25,783,3393.59%
TSP Capital Management Group, LLC 251,895$8,546,8003.08%
ACUTA CAPITAL PARTNERS, LLC 122,343$4,151,0982.81%
5AM Venture Management, LLC 310,270$10,527,4612.62%
COMMODORE CAPITAL LP 631,665$21,432,3932.41%
RTW INVESTMENTS, LP 3,463,201$117,506,4102.24%
Eversept Partners, LP 785,740$26,660,1582.23%
Redmile Group, LLC 1,696,004$57,545,4162.21%
Affinity Asset Advisors, LLC 87,031$2,952,9621.03%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders